Literature DB >> 11042174

Unique oxidative mechanisms for the reactive nitrogen oxide species, nitroxyl anion.

K M Miranda1, M G Espey, K Yamada, M Krishna, N Ludwick, S Kim, D Jourd'heuil, M B Grisham, M Feelisch, J M Fukuto, D A Wink.   

Abstract

The nitroxyl anion (NO-) is a highly reactive molecule that may be involved in pathophysiological actions associated with increased formation of reactive nitrogen oxide species. Angeli's salt (Na2N2O3; AS) is a NO- donor that has been shown to exert marked cytotoxicity. However, its decomposition intermediates have not been well characterized. In this study, the chemical reactivity of AS was examined and compared with that of peroxynitrite (ONOO-) and NO/N2O3. Under aerobic conditions, AS and ONOO- exhibited similar and considerably higher affinities for dihydrorhodamine (DHR) than NO/N2O3. Quenching of DHR oxidation by azide and nitrosation of diaminonaphthalene were exclusively observed with NO/N2O3. Additional comparison of ONOO- and AS chemistry demonstrated that ONOO- was a far more potent one-electron oxidant and nitrating agent of hydroxyphenylacetic acid than was AS. However, AS was more effective at hydroxylating benzoic acid than was ONOO-. Taken together, these data indicate that neither NO/N2O3 nor ONOO- is an intermediate of AS decomposition. Evaluation of the stoichiometry of AS decomposition and O2 consumption revealed a 1:1 molar ratio. Indeed, oxidation of DHR mediated by AS proved to be oxygen-dependent. Analysis of the end products of AS decomposition demonstrated formation of NO2- and NO3- in approximately stoichiometric ratios. Several mechanisms are proposed for O2 adduct formation followed by decomposition to NO3- or by oxidation of an HN2O3- molecule to form NO2-. Given that the cytotoxicity of AS is far greater than that of either NO/N2O3 or NO + O2, this study provides important new insights into the implications of the potential endogenous formation of NO- under inflammatory conditions in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11042174     DOI: 10.1074/jbc.M006174200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from beta-adrenergic signaling.

Authors:  Nazareno Paolocci; Tatsuo Katori; Hunter C Champion; Marcus E St John; Katrina M Miranda; Jon M Fukuto; David A Wink; David A Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

Review 2.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

Review 3.  The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO.

Authors:  Nazareno Paolocci; Matthew I Jackson; Brenda E Lopez; Katrina Miranda; Carlo G Tocchetti; David A Wink; Adrian J Hobbs; Jon M Fukuto
Journal:  Pharmacol Ther       Date:  2006-11-29       Impact factor: 12.310

4.  Involvement of electron and hydrogen transfers through redox metabolism on activity and toxicity of the nimesulide.

Authors:  Rosivaldo S Borges; Juliana P Oliveira; Rafaelle F Matos; Antonio M J Chaves Neto; Agnaldo S Carneiro; Marta C Monteiro
Journal:  J Mol Model       Date:  2015-06-06       Impact factor: 1.810

Review 5.  The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems.

Authors:  Wilmarie Flores-Santana; Debra J Salmon; Sonia Donzelli; Christopher H Switzer; Debashree Basudhar; Lisa Ridnour; Robert Cheng; Sharon A Glynn; Nazareno Paolocci; Jon M Fukuto; Katrina M Miranda; David A Wink
Journal:  Antioxid Redox Signal       Date:  2011-03-16       Impact factor: 8.401

6.  Nitroxyl accelerates the oxidation of oxyhemoglobin by nitrite.

Authors:  Landon Bellavia; Jenna F DuMond; Andreas Perlegas; S Bruce King; Daniel B Kim-Shapiro
Journal:  Nitric Oxide       Date:  2013-03-30       Impact factor: 4.427

7.  Glutathione sulfinamide serves as a selective, endogenous biomarker for nitroxyl after exposure to therapeutic levels of donors.

Authors:  Gail M Johnson; Tyler J Chozinski; Elyssia S Gallagher; Craig A Aspinwall; Katrina M Miranda
Journal:  Free Radic Biol Med       Date:  2014-07-23       Impact factor: 7.376

8.  The reduction potential of nitric oxide (NO) and its importance to NO biochemistry.

Authors:  Michael D Bartberger; Wei Liu; Eleonora Ford; Katrina M Miranda; Christopher Switzer; Jon M Fukuto; Patrick J Farmer; David A Wink; Kendall N Houk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

Review 9.  Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure.

Authors:  Barbara K Kemp-Harper; John D Horowitz; Rebecca H Ritchie
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

10.  A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system.

Authors:  Katrina M Miranda; Nazareno Paolocci; Tatsuo Katori; Douglas D Thomas; Eleonora Ford; Michael D Bartberger; Michael G Espey; David A Kass; Martin Feelisch; Jon M Fukuto; David A Wink
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.